Research And Grants

CONNECT Consortium (TarGeT 2027) - $6,445 USD / $10,000 AUD

Dr. Nick Gottardo
Grant Amount

$6,445.00

Date

December 2024

Research Type

Clinical

Cancer Type

DIPG/DMG


TarGeT 2027

  • Precision Medicine: TarGeT aligns with emerging data suggesting that personalised treatment significantly enhances outcomes for high-risk brain cancers.
  • Local Participation: The trial will involve five CONNECT member hospitals across Australasia, enabling substantial enrolment from local young patients.
  • Global Collaboration: ANZCHOG’s coordination with CONNECT will allow Australian and New Zealand patients to access globally recognised, cutting-edge therapies developed through extensive international collaboration.